Conversely, downregulation or absence of SIRT3 was associated with decreased cardiac recovery and increased infarct size (Porter et al., 2014), enhanced doxorubicin-induced cardiac hypertrophy (Pillai et al., 2016) and H2O2-induced neuronal injury (Dai et al., 2014). Here, SIRT3 is linked to cardiac hypertrophy.